Pineapple gel approved for burns


A topical gel based on pineapple enzymes has been approved in the EU for use in the treatment of burns.

NexoBrid gel from privately owned biotech MediWound, contains proteolytic enzymes from the stem of the pineapple plant. It is the first pharmacological treatment for the removal of scab tissue associated with severe burns, which are typically removed surgically. Removal of scab tissue is essential to speed the healing process and prevent infection.

NexoBrid gel was designated an orphan medicine in 2002. Israeli generics giants Teva paid $163 million to raise its stake in Mediwound from 14% to 51% in 2010, according to Reuters.


Related Content

Myelofibrosis drug approved in EU

28 August 2012 Business

news image

Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow

Business roundup

28 March 2012 Business

news image

Industry news, April 2012

Most Read

Isotope effect produces new type of chemical bond

22 October 2014 Research

news image

Evidence emerges for vibrational bond first proposed 30 years ago

DNA 'barcodes' used to track food

30 October 2014 Research

news image

Milk has been successfully tracked as it is turned into cheese and yogurt in an advance that could fight food fraud

Most Commented

Square planar iron complex breaks inorganic dogma

31 October 2014 Research

news image

Unusual spin state could open the door to new and exciting chemistry

Indian U-turn on diabetes drug ban

16 August 2013 News and Analysis

news image

Suspension of cheap and popular medicine reversed but will now come with new safety warnings